aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability

Meghan Riddell, Akiko Nakayama, Takao Hikita, Fatemeh Mirzapourshafiyi, Takuji Kawamura, Ayesha Pasha, Mengnan Li, Mikio Masuzawa, Mario Looso, Tim Steinbacher, Klaus Ebnet, Michael Potente, Tomonori Hirose, Shigeo Ohno, Ingrid Fleming, Stefan Gattenlöhner, Phyu P. Aung, Thuy Phung, Osamu Yamasaki, Teruki YanagiHiroshi Umemura, Masanori Nakayama

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Strict regulation of proliferation is vital for development, whereas unregulated cell proliferation is a fundamental characteristic of cancer. The polarity protein atypical protein kinase C lambda/iota (aPKCλ) is associated with cell proliferation through unknown mechanisms. In endothelial cells, suppression of aPKCλ impairs proliferation despite hyperactivated mitogenic signaling. Here we show that aPKCλ phosphorylates the DNA binding domain of forkhead box O1 (FoxO1) transcription factor, a gatekeeper of endothelial growth. Although mitogenic signaling excludes FoxO1 from the nucleus, consequently increasing c-Myc abundance and proliferation, aPKCλ controls c-Myc expression via FoxO1/miR-34c signaling without affecting its localization. We find this pathway is strongly activated in the malignant vascular sarcoma, angiosarcoma, and aPKC inhibition reduces c-Myc expression and proliferation of angiosarcoma cells. Moreover, FoxO1 phosphorylation at Ser218 and aPKC expression correlates with poor patient prognosis. Our findings may provide a potential therapeutic strategy for treatment of malignant cancers, like angiosarcoma.

Original languageEnglish
Article number5357
JournalNature Communications
Volume9
Issue number1
DOIs
Publication statusPublished - Dec 1 2018

Fingerprint

boxes
deoxyribonucleic acid
proteins
DNA
Growth
Cell proliferation
cancer
Hemangiosarcoma
Phosphorylation
Endothelial cells
Cell Proliferation
phosphorylation
prognosis
protein kinase C lambda
Transcription Factors
polarity
Forkhead Transcription Factors
retarding
nuclei
Sarcoma

ASJC Scopus subject areas

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Physics and Astronomy(all)

Cite this

Riddell, M., Nakayama, A., Hikita, T., Mirzapourshafiyi, F., Kawamura, T., Pasha, A., ... Nakayama, M. (2018). aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability. Nature Communications, 9(1), [5357]. https://doi.org/10.1038/s41467-018-07739-0

aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability. / Riddell, Meghan; Nakayama, Akiko; Hikita, Takao; Mirzapourshafiyi, Fatemeh; Kawamura, Takuji; Pasha, Ayesha; Li, Mengnan; Masuzawa, Mikio; Looso, Mario; Steinbacher, Tim; Ebnet, Klaus; Potente, Michael; Hirose, Tomonori; Ohno, Shigeo; Fleming, Ingrid; Gattenlöhner, Stefan; Aung, Phyu P.; Phung, Thuy; Yamasaki, Osamu; Yanagi, Teruki; Umemura, Hiroshi; Nakayama, Masanori.

In: Nature Communications, Vol. 9, No. 1, 5357, 01.12.2018.

Research output: Contribution to journalArticle

Riddell, M, Nakayama, A, Hikita, T, Mirzapourshafiyi, F, Kawamura, T, Pasha, A, Li, M, Masuzawa, M, Looso, M, Steinbacher, T, Ebnet, K, Potente, M, Hirose, T, Ohno, S, Fleming, I, Gattenlöhner, S, Aung, PP, Phung, T, Yamasaki, O, Yanagi, T, Umemura, H & Nakayama, M 2018, 'aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability', Nature Communications, vol. 9, no. 1, 5357. https://doi.org/10.1038/s41467-018-07739-0
Riddell M, Nakayama A, Hikita T, Mirzapourshafiyi F, Kawamura T, Pasha A et al. aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability. Nature Communications. 2018 Dec 1;9(1). 5357. https://doi.org/10.1038/s41467-018-07739-0
Riddell, Meghan ; Nakayama, Akiko ; Hikita, Takao ; Mirzapourshafiyi, Fatemeh ; Kawamura, Takuji ; Pasha, Ayesha ; Li, Mengnan ; Masuzawa, Mikio ; Looso, Mario ; Steinbacher, Tim ; Ebnet, Klaus ; Potente, Michael ; Hirose, Tomonori ; Ohno, Shigeo ; Fleming, Ingrid ; Gattenlöhner, Stefan ; Aung, Phyu P. ; Phung, Thuy ; Yamasaki, Osamu ; Yanagi, Teruki ; Umemura, Hiroshi ; Nakayama, Masanori. / aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability. In: Nature Communications. 2018 ; Vol. 9, No. 1.
@article{4192bc6f3f294c59bc82ae165bb83872,
title = "aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability",
abstract = "Strict regulation of proliferation is vital for development, whereas unregulated cell proliferation is a fundamental characteristic of cancer. The polarity protein atypical protein kinase C lambda/iota (aPKCλ) is associated with cell proliferation through unknown mechanisms. In endothelial cells, suppression of aPKCλ impairs proliferation despite hyperactivated mitogenic signaling. Here we show that aPKCλ phosphorylates the DNA binding domain of forkhead box O1 (FoxO1) transcription factor, a gatekeeper of endothelial growth. Although mitogenic signaling excludes FoxO1 from the nucleus, consequently increasing c-Myc abundance and proliferation, aPKCλ controls c-Myc expression via FoxO1/miR-34c signaling without affecting its localization. We find this pathway is strongly activated in the malignant vascular sarcoma, angiosarcoma, and aPKC inhibition reduces c-Myc expression and proliferation of angiosarcoma cells. Moreover, FoxO1 phosphorylation at Ser218 and aPKC expression correlates with poor patient prognosis. Our findings may provide a potential therapeutic strategy for treatment of malignant cancers, like angiosarcoma.",
author = "Meghan Riddell and Akiko Nakayama and Takao Hikita and Fatemeh Mirzapourshafiyi and Takuji Kawamura and Ayesha Pasha and Mengnan Li and Mikio Masuzawa and Mario Looso and Tim Steinbacher and Klaus Ebnet and Michael Potente and Tomonori Hirose and Shigeo Ohno and Ingrid Fleming and Stefan Gattenl{\"o}hner and Aung, {Phyu P.} and Thuy Phung and Osamu Yamasaki and Teruki Yanagi and Hiroshi Umemura and Masanori Nakayama",
year = "2018",
month = "12",
day = "1",
doi = "10.1038/s41467-018-07739-0",
language = "English",
volume = "9",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability

AU - Riddell, Meghan

AU - Nakayama, Akiko

AU - Hikita, Takao

AU - Mirzapourshafiyi, Fatemeh

AU - Kawamura, Takuji

AU - Pasha, Ayesha

AU - Li, Mengnan

AU - Masuzawa, Mikio

AU - Looso, Mario

AU - Steinbacher, Tim

AU - Ebnet, Klaus

AU - Potente, Michael

AU - Hirose, Tomonori

AU - Ohno, Shigeo

AU - Fleming, Ingrid

AU - Gattenlöhner, Stefan

AU - Aung, Phyu P.

AU - Phung, Thuy

AU - Yamasaki, Osamu

AU - Yanagi, Teruki

AU - Umemura, Hiroshi

AU - Nakayama, Masanori

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Strict regulation of proliferation is vital for development, whereas unregulated cell proliferation is a fundamental characteristic of cancer. The polarity protein atypical protein kinase C lambda/iota (aPKCλ) is associated with cell proliferation through unknown mechanisms. In endothelial cells, suppression of aPKCλ impairs proliferation despite hyperactivated mitogenic signaling. Here we show that aPKCλ phosphorylates the DNA binding domain of forkhead box O1 (FoxO1) transcription factor, a gatekeeper of endothelial growth. Although mitogenic signaling excludes FoxO1 from the nucleus, consequently increasing c-Myc abundance and proliferation, aPKCλ controls c-Myc expression via FoxO1/miR-34c signaling without affecting its localization. We find this pathway is strongly activated in the malignant vascular sarcoma, angiosarcoma, and aPKC inhibition reduces c-Myc expression and proliferation of angiosarcoma cells. Moreover, FoxO1 phosphorylation at Ser218 and aPKC expression correlates with poor patient prognosis. Our findings may provide a potential therapeutic strategy for treatment of malignant cancers, like angiosarcoma.

AB - Strict regulation of proliferation is vital for development, whereas unregulated cell proliferation is a fundamental characteristic of cancer. The polarity protein atypical protein kinase C lambda/iota (aPKCλ) is associated with cell proliferation through unknown mechanisms. In endothelial cells, suppression of aPKCλ impairs proliferation despite hyperactivated mitogenic signaling. Here we show that aPKCλ phosphorylates the DNA binding domain of forkhead box O1 (FoxO1) transcription factor, a gatekeeper of endothelial growth. Although mitogenic signaling excludes FoxO1 from the nucleus, consequently increasing c-Myc abundance and proliferation, aPKCλ controls c-Myc expression via FoxO1/miR-34c signaling without affecting its localization. We find this pathway is strongly activated in the malignant vascular sarcoma, angiosarcoma, and aPKC inhibition reduces c-Myc expression and proliferation of angiosarcoma cells. Moreover, FoxO1 phosphorylation at Ser218 and aPKC expression correlates with poor patient prognosis. Our findings may provide a potential therapeutic strategy for treatment of malignant cancers, like angiosarcoma.

UR - http://www.scopus.com/inward/record.url?scp=85058739093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058739093&partnerID=8YFLogxK

U2 - 10.1038/s41467-018-07739-0

DO - 10.1038/s41467-018-07739-0

M3 - Article

C2 - 30559384

AN - SCOPUS:85058739093

VL - 9

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

IS - 1

M1 - 5357

ER -